law://au/li/2020/f2020l00511@2026-11-13| Group T11—Botulinum toxin | ||
|---|---|---|
| Column 1Item | Column 2Description | Column 3Fee ($) |
| 18365 | Botulinum Toxin Type A Purified Neurotoxin Complex (Botox) or Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport) or IncobotulinumtoxinA (Xeomin), injection of, for the treatment of moderate to severe spasticity of the upper limb following an acute event, if:(a) the patient is at least 18 years of age; and(b) treatment is provided as:(i) second line therapy when standard treatment for the condition has failed; or(ii) an adjunct to physical therapy; and(c) the patient does not have established severe contracture in the limb that is to be treated; and(d) the treatment is for all or any of the muscles subserving one functional activity and supplied by one motor nerve, with a maximum of 4 sets of injections for the patient on any one day (with a maximum of 2 sets of injections for each upper limb), including all injections per set; and(e) for a patient who has received treatment on 2 previous separate occasions—the patient has responded to the treatment | 129.90 |
Sourced from the Federal Register of Legislation at legislation.gov.au, © Commonwealth of Australia, licensed under CC BY 4.0. Compilations may have been reformatted.